Get the Stockscreener App
1.795
2.72%
-0.045
Repare Therapeutics Inc stock is traded at $1.795, with a volume of 81,504.
It is down -2.72% in the last 24 hours and down -0.56% over the past month.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
See More
Previous Close:
$1.84
Open:
$1.84
24h Volume:
81,504
Relative Volume:
0.66
Market Cap:
$76.90M
Revenue:
$51.13M
Net Income/Loss:
$-93.80M
P/E Ratio:
-0.8049
EPS:
-2.23
Net Cash Flow:
$-129.10M
1W Performance:
-4.28%
1M Performance:
-0.56%
6M Performance:
+25.17%
1Y Performance:
-50.00%
1-Day Range:
$1.77
$1.86
1-Week Range:
$1.72
$1.885
52-Week Range:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
Name
Repare Therapeutics Inc
Sector
Industry
Phone
(857) 412-7018
Address
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Compare RPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.79 | 79.04M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
638.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.90 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.39 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.24 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-23 | Upgrade | Stifel | Hold → Buy |
| Feb-03-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-06-23 | Initiated | CapitalOne | Overweight |
| Apr-12-22 | Downgrade | Stifel | Buy → Hold |
| Mar-17-22 | Resumed | Goldman | Buy |
| Sep-23-21 | Initiated | Stifel | Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Buy |
| Jun-28-21 | Initiated | Guggenheim | Buy |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Oct-28-20 | Initiated | Northland Capital | Outperform |
| Jul-14-20 | Initiated | Cowen | Outperform |
| Jul-14-20 | Initiated | Goldman | Neutral |
| Jul-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-14-20 | Initiated | Piper Sandler | Overweight |
View All
Repare Therapeutics Inc Stock (RPTX) Latest News
Analyzing Repare Therapeutics Inc. with multi timeframe charts2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
How Repare Therapeutics Inc. stock compares to industry benchmarks2025 Market Outlook & Risk Managed Investment Strategies - newser.com
Is Repare Therapeutics Inc. stock near bottom after declineJuly 2025 Update & Fast Gain Swing Alerts - newser.com
Why Repare Therapeutics Inc. stock remains resilient2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com
Candlestick signals on Repare Therapeutics Inc. stock todayGold Moves & Fast Exit and Entry Strategy Plans - newser.com
How to monitor Repare Therapeutics Inc. with trend dashboardsWeekly Stock Summary & Technical Buy Zone Confirmations - newser.com
Volume spikes in Repare Therapeutics Inc. stock – what they meanOptions Play & Long-Term Capital Growth Ideas - newser.com
Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Published on: 2025-11-01 00:17:06 - newser.com
Is Repare Therapeutics Inc. stock attractive for ETFs2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
Repare Therapeutics (RPTX) Projected to Post Earnings on Thursday - MarketBeat
Real time scanner hits for Repare Therapeutics Inc. explained2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
How to interpret RSI for Repare Therapeutics Inc. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Risk adjusted return profile for Repare Therapeutics Inc. analyzedJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Repare Therapeutics Inc. (RPTX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
HC Wainwright Issues Positive Outlook for RPTX Earnings - MarketBeat
Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely - Yahoo Finance
Q3 EPS Forecast for Repare Therapeutics Increased by Analyst - Defense World
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look - MSN
Q1 Earnings Forecast for RPTX Issued By HC Wainwright - MarketBeat
Can Repare Therapeutics Inc. stock deliver sustainable ROEQuarterly Earnings Report & High Accuracy Buy Signal Tips - Fundação Cultural do Pará
Repare Therapeutics stock price target cut as H.C. Wainwright questions drug candidate - Investing.com Nigeria
Repare Therapeutics (NASDAQ:RPTX) Given New $3.00 Price Target at HC Wainwright - Defense World
HC Wainwright & Co. Maintains Repare Therapeutics (RPTX) Buy Recommendation - Nasdaq
RPTX Analyst Forecasts - Quiver Quantitative
HC Wainwright Has Lowered Expectations for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat
RPTX: Analyst Lowers Target Price While Maintaining Buy Rating | - GuruFocus
Can Repare Therapeutics Inc. stock beat analyst upgrades2025 Big Picture & Low Drawdown Investment Ideas - fcp.pa.gov.br
Repare Therapeutics Inc Stock (RPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):